Identification of TMB, CD8 T-cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit-toxicity ratio of anti-PD-1/PD-L1 therapy.

Clin Transl Med

Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.

Published: November 2021

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597891	PMC
http://dx.doi.org/10.1002/ctm2.598	DOI Listing

Publication Analysis

identification tmb

tmb cd8

cd8 t-cell

t-cell abundance

abundance homologous

homologous repair

repair pathway

pathway mutation

mutation frequency

frequency predictors

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!